Company profile for Kancera

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kancera develops drugs for inflammation and cancer. Evidence in humans guides clinical Phase IIa study in cardiovascular inflammation. Kancera develops novel drugs that counteract damage during acute & chronic inflammation. Kancera also develops preclinical drug projects against cancer aimed at stopping survival signals in the cancer cell and preventing the cancer cell’s ability to be repaired. Kancera has five drug project...
Kancera develops drugs for inflammation and cancer. Evidence in humans guides clinical Phase IIa study in cardiovascular inflammation. Kancera develops novel drugs that counteract damage during acute & chronic inflammation. Kancera also develops preclinical drug projects against cancer aimed at stopping survival signals in the cancer cell and preventing the cancer cell’s ability to be repaired. Kancera has five drug projects in the portfolio. Kancera’s main resources are invested in two Fractalkine projects. The further development of the HDAC project is externally financed through agreement with the pharmaceutical company Grünenthal.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Karolinska Institutet Science Park Banvaktsvägen 22 SE-171 48 Solna
Telephone
Telephone
+46 (0)850 12 60 80
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2024-05-03/kancera-meets-the-primary-objectives-of-the-kand145-clinical-phase-i-study

PHARMIWEB
03 May 2024

https://www.clinicaltrialsarena.com/news/kancera-doses-patient-ovarian-cancer/

CLINICAL TRIALS ARENA
20 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty